Vanessa atalanta chromosome 30, ilVanAtal1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Nymphalidae; Nymphalinae; Vanessa.
REFSEQ INFORMATION: The reference sequence is identical to\nLR990580.1.\nAssembly name: ilVanAtal1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Wellcome Sanger Institute on\n2021/09/28. The original whole-genome shotgun project has the\naccession CAJHWX000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vanessa atalanta Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
COORDINATES: nucleotide motif:Rfam:12.0:RF01960
COORDINATES: nucleotide motif:Rfam:12.0:RF02543
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase ULK3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
U1 small nuclear ribonucleoprotein 70 kDa
RNA pseudouridylate synthase domain-containing protein 1-like
mitochondrial ribosome-associated GTPase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 47% coverage of the annotated genomic feature by RNAseq alignments
M-phase inducer phosphatase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
M-phase inducer phosphatase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
M-phase inducer phosphatase-like isoform X1
M-phase inducer phosphatase-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
esterase FE4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
esterase FE4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X3
4-hydroxybenzoate polyprenyltransferase, mitochondrial
uncharacterized LOC125075141, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125075141, transcript variant X5
uncharacterized LOC125075141, transcript variant X6
uncharacterized LOC125075141, transcript variant X3
uncharacterized LOC125075141, transcript variant X8
uncharacterized LOC125075141, transcript variant X9
uncharacterized LOC125075141, transcript variant X1
uncharacterized LOC125075141, transcript variant X7
uncharacterized LOC125075141, transcript variant X10
uncharacterized LOC125075141, transcript variant X4
uncharacterized protein LOC125075141 isoform X2
uncharacterized protein LOC125075141 isoform X1
uncharacterized protein LOC125075141 isoform X5
uncharacterized protein LOC125075141 isoform X6
uncharacterized protein LOC125075141 isoform X3
uncharacterized protein LOC125075141 isoform X7
uncharacterized protein LOC125075141 isoform X8
uncharacterized protein LOC125075141 isoform X9
uncharacterized protein LOC125075141 isoform X10
uncharacterized protein LOC125075141 isoform X4
eukaryotic translation initiation factor 4 gamma-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 90-like, transcript variant X1
zinc finger protein 90-like, transcript variant X3
zinc finger protein 90-like, transcript variant X4
zinc finger protein 90-like, transcript variant X2
zinc finger protein 90-like, transcript variant X5
cytotoxic granule associated RNA binding protein TIA1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
guanine nucleotide-binding protein-like 1, transcript variant X1
guanine nucleotide-binding protein-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein-like 1
U6 snRNA-associated Sm-like protein LSm4
endoribonuclease Dcr-1-like, transcript variant X2
endoribonuclease Dcr-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adenylyltransferase and sulfurtransferase MOCS3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
translational regulator orb2, transcript variant X1
translational regulator orb2, transcript variant X2
cytoplasmic polyadenylation element-binding protein 2 isoform X1
probable galactose-1-phosphate uridylyltransferase, transcript variant X1
probable galactose-1-phosphate uridylyltransferase isoform X1
probable galactose-1-phosphate uridylyltransferase, transcript variant X3
probable galactose-1-phosphate uridylyltransferase isoform X3
probable galactose-1-phosphate uridylyltransferase, transcript variant X2
probable galactose-1-phosphate uridylyltransferase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UDP-N-acetylhexosamine pyrophosphorylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X4
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
motile sperm domain-containing protein 2-like
adenosine 5'-monophosphoramidase HINT3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
heart- and neural crest derivatives-expressed protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
heart- and neural crest derivatives-expressed protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heart- and neural crest derivatives-expressed protein 2, transcript variant X1
heart- and neural crest derivatives-expressed protein 2 isoform X2
heart- and neural crest derivatives-expressed protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear pore complex protein Nup98-Nup96
uncharacterized LOC125075166, transcript variant X2
uncharacterized LOC125075166, transcript variant X1
uncharacterized protein LOC125075166 isoform X2
uncharacterized protein LOC125075166 isoform X1
uncharacterized LOC125075174, transcript variant X3
uncharacterized LOC125075174, transcript variant X1
uncharacterized LOC125075174, transcript variant X2
uncharacterized protein LOC125075174 isoform X2
uncharacterized protein LOC125075174 isoform X1
uncharacterized LOC125075165, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125075165, transcript variant X1
uncharacterized protein LOC125075165 isoform X2
uncharacterized protein LOC125075165 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gastrula zinc finger protein XlCGF49.1-like, transcript variant X2
gastrula zinc finger protein XlCGF49.1-like, transcript variant X1
gastrula zinc finger protein XlCGF49.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 43% coverage of the annotated genomic feature by RNAseq alignments
spermine oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
spermine oxidase-like, transcript variant X2
spermine oxidase-like, transcript variant X4
spermine oxidase-like, transcript variant X3
UPF0547 protein C16orf87 homolog, transcript variant X2
UPF0547 protein C16orf87 homolog, transcript variant X1
UPF0547 protein C16orf87 homolog isoform X2
UPF0547 protein C16orf87 homolog isoform X1
zinc finger protein 54-like, transcript variant X1
zinc finger protein 54-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein MAL13P1.304-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
monocarboxylate transporter 12, transcript variant X2
monocarboxylate transporter 12, transcript variant X1
uncharacterized protein LOC125075170 isoform X2
monocarboxylate transporter 12 isoform X1
xaa-Pro aminopeptidase ApepP-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
xaa-Pro aminopeptidase ApepP-like, transcript variant X1
xaa-Pro aminopeptidase ApepP-like isoform X1
xaa-Pro aminopeptidase ApepP-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thyrotropin-releasing hormone-degrading ectoenzyme-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
oxysterol-binding protein-related protein 8
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
28S ribosomal protein S35, mitochondrial
zinc finger protein Xfin-like, transcript variant X1
zinc finger protein Xfin-like, transcript variant X2
zinc finger protein Xfin-like isoform X2
la-related protein 1, transcript variant X3
la-related protein 1, transcript variant X4
la-related protein 1, transcript variant X1
la-related protein 1, transcript variant X2
uncharacterized LOC125075156, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125075156, transcript variant X2
uncharacterized protein LOC125075156 isoform X1
uncharacterized protein LOC125075156 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125075156, transcript variant X3
uncharacterized LOC125075156, transcript variant X4
uncharacterized protein LOC125075156 isoform X3
uncharacterized protein PF3D7_1225600-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X46
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X45
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X40
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X43
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X17
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X48
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X44
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X42
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X38
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X37
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X47
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X35
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X41
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X39
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X31
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X8
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X32
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X25
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X36
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X7
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X50
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X34
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X30
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X49
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X27
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X33
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X28
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X9
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X24
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X3
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X13
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X14
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X16
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X10
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X29
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X4
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X18
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X6
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X11
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X5
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X15
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X12
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X19
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X20
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X26
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X23
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X22
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X21
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X1
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X46
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X45
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X40
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X43
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X17
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X48
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X44
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X42
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X38
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X37
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X47
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X35
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X41
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X39
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X31
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X8
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X32
collagen alpha-1(III) chain-like isoform X25
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X36
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X7
trithorax group protein osa-like isoform X50
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X34
collagen alpha-1(III) chain-like isoform X30
collagen alpha-1(III) chain-like isoform X49
collagen alpha-1(III) chain-like isoform X27
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X33
collagen alpha-1(III) chain-like isoform X28
collagen alpha-1(III) chain-like isoform X9
collagen alpha-1(III) chain-like isoform X24
collagen alpha-1(III) chain-like isoform X3
collagen alpha-1(I) chain-like isoform X13
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X14
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X16
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X10
collagen alpha-1(III) chain-like isoform X29
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X4
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X18
collagen alpha-1(III) chain-like isoform X6
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X11
collagen alpha-1(III) chain-like isoform X5
collagen alpha-1(III) chain-like isoform X15
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X12
collagen alpha-1(III) chain-like isoform X19
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X20
collagen alpha-1(III) chain-like isoform X26
collagen alpha-1(III) chain-like isoform X23
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X22
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X21
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X1
probable serine/threonine-protein kinase clkA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125075222, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125075222, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leishmanolysin-like peptidase, transcript variant X2
leishmanolysin-like peptidase, transcript variant X1
leishmanolysin-like peptidase isoform X2
leishmanolysin-like peptidase isoform X1
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X2
zinc finger protein 184-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X2
zinc finger protein 436-like, transcript variant X1
zinc finger protein 436-like, transcript variant X2
zinc finger and BTB domain-containing protein 24-like, transcript variant X2
zinc finger and BTB domain-containing protein 24-like, transcript variant X1
zinc finger and BTB domain-containing protein 24-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein DDB_G0290685-like
intersectin-1-like, transcript variant X2
intersectin-1-like, transcript variant X1
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF220, transcript variant X2
E3 ubiquitin-protein ligase RNF220, transcript variant X1
E3 ubiquitin-protein ligase RNF220 isoform X2
E3 ubiquitin-protein ligase RNF220 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 596-like, transcript variant X1
zinc finger protein 596-like, transcript variant X2
signal transducer and activator of transcription 5B, transcript variant X2
signal transducer and activator of transcription 5B, transcript variant X3
signal transducer and activator of transcription 5B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X1
signal transducer and activator of transcription 5B isoform X1
signal transducer and activator of transcription 5B isoform X2
signal transducer and activator of transcription 5B isoform X3
signal transducer and activator of transcription 5B isoform X4
zinc finger protein 91-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 91-like, transcript variant X2
zinc finger protein 91-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X3
tubulin beta chain-like, transcript variant X2
tubulin beta chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine protease snake-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine protease snake-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
putative fatty acyl-CoA reductase CG5065
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
prion-like-(Q/N-rich) domain-bearing protein 25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125075302, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125075302, transcript variant X2
uncharacterized LOC125075302, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125075302 isoform X1
uncharacterized protein LOC125075302 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
inactive peptidyl-prolyl cis-trans isomerase shutdown-like
multiple coagulation factor deficiency protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
actin depolymerising venom protein gelsolin 1-like
L-dopachrome tautomerase yellow-f-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
L-dopachrome tautomerase yellow-f-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
L-dopachrome tautomerase yellow-f-like, transcript variant X2
MATH and LRR domain-containing protein PFE0570w-like
uncharacterized LOC125075261, transcript variant X4
uncharacterized LOC125075261, transcript variant X3
uncharacterized protein LOC125075261 isoform X4
uncharacterized protein LOC125075261 isoform X3
uncharacterized LOC125075261, transcript variant X1
uncharacterized LOC125075261, transcript variant X2
uncharacterized protein LOC125075261 isoform X1
uncharacterized protein LOC125075261 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
segmentation protein cap'n'collar-like, transcript variant X8
segmentation protein cap'n'collar-like isoform X6
segmentation protein cap'n'collar-like, transcript variant X1
segmentation protein cap'n'collar-like, transcript variant X2
segmentation protein cap'n'collar-like, transcript variant X3
segmentation protein cap'n'collar-like, transcript variant X6
segmentation protein cap'n'collar-like, transcript variant X4
segmentation protein cap'n'collar-like, transcript variant X5
segmentation protein cap'n'collar-like, transcript variant X7
endoplasmic reticulum membrane sensor NFE2L1-like isoform X1
endoplasmic reticulum membrane sensor NFE2L1-like isoform X4
endoplasmic reticulum membrane sensor NFE2L1-like isoform X2
endoplasmic reticulum membrane sensor NFE2L1-like isoform X3
segmentation protein cap'n'collar-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidylserine decarboxylase proenzyme, mitochondrial
solute carrier family 25 member 44, transcript variant X2
solute carrier family 25 member 44, transcript variant X1
uncharacterized LOC125075366, transcript variant X6
uncharacterized LOC125075366, transcript variant X1
uncharacterized LOC125075366, transcript variant X5
uncharacterized LOC125075366, transcript variant X4
uncharacterized LOC125075366, transcript variant X7
uncharacterized LOC125075366, transcript variant X2
uncharacterized LOC125075366, transcript variant X9
uncharacterized LOC125075366, transcript variant X3
uncharacterized LOC125075366, transcript variant X8
uncharacterized protein LOC125075366 isoform X6
uncharacterized protein LOC125075366 isoform X1
uncharacterized protein LOC125075366 isoform X5
uncharacterized protein LOC125075366 isoform X4
uncharacterized protein LOC125075366 isoform X7
uncharacterized protein LOC125075366 isoform X2
uncharacterized protein LOC125075366 isoform X8
uncharacterized protein LOC125075366 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3, transcript variant X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 isoform X2
S-phase kinase-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
lysosomal alpha-mannosidase-like, transcript variant X1
lysosomal alpha-mannosidase-like, transcript variant X3
lysosomal alpha-mannosidase-like, transcript variant X2
lysosomal alpha-mannosidase-like isoform X1
lysosomal alpha-mannosidase-like isoform X3
lysosomal alpha-mannosidase-like isoform X2
cytoplasmic aconitate hydratase-like, transcript variant X1
cytoplasmic aconitate hydratase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin-related modifier 1, transcript variant X2
ubiquitin-related modifier 1, transcript variant X1
ubiquitin-related modifier 1, transcript variant X3
leucine-rich repeat extensin-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 37-like, transcript variant X1
zinc finger protein 37-like, transcript variant X2
zinc finger protein 37-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 427 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC125075316, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125075316, transcript variant X1
uncharacterized LOC125075316, transcript variant X3
uncharacterized LOC125075316, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial coenzyme A transporter SLC25A42, transcript variant X1
mitochondrial coenzyme A transporter SLC25A42, transcript variant X2
mitochondrial coenzyme A transporter SLC25A42 isoform X1
mitochondrial coenzyme A transporter SLC25A42 isoform X2
retroviral integration site protein Fli-1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments